| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Liver Cirrhosis | 16 | 2019 | 1810 | 4.11 | Why? |
| Hepatitis B, Chronic | 10 | 2018 | 616 | 3.36 | Why? |
| Hepatitis B | 9 | 2019 | 888 | 2.73 | Why? |
| Hepatitis B virus | 9 | 2018 | 882 | 2.67 | Why? |
| Acute-On-Chronic Liver Failure | 5 | 2019 | 237 | 2.46 | Why? |
| Liver, Artificial | 3 | 2021 | 48 | 2.41 | Why? |
| beta-Lactamases | 7 | 2018 | 759 | 2.30 | Why? |
| Liver Failure, Acute | 5 | 2019 | 279 | 2.25 | Why? |
| Influenza A Virus, H7N9 Subtype | 6 | 2019 | 415 | 2.15 | Why? |
| Escherichia coli Proteins | 3 | 2018 | 168 | 1.93 | Why? |
| Metabolome | 7 | 2019 | 624 | 1.81 | Why? |
| Gastrointestinal Microbiome | 9 | 2021 | 1961 | 1.77 | Why? |
| Liver Failure | 3 | 2019 | 266 | 1.67 | Why? |
| Liver | 12 | 2020 | 4007 | 1.63 | Why? |
| Escherichia coli | 4 | 2018 | 1547 | 1.60 | Why? |
| Plasmids | 5 | 2018 | 840 | 1.58 | Why? |
| Isotope Labeling | 3 | 2018 | 39 | 1.57 | Why? |
| Hepatitis B Surface Antigens | 6 | 2019 | 305 | 1.44 | Why? |
| Carcinoma, Hepatocellular | 6 | 2018 | 1222 | 1.42 | Why? |
| Liver Neoplasms | 6 | 2018 | 1666 | 1.25 | Why? |
| Metabolomics | 5 | 2019 | 921 | 1.25 | Why? |
| Chromatography, Liquid | 3 | 2018 | 640 | 1.18 | Why? |
| Escherichia coli Infections | 2 | 2017 | 348 | 1.05 | Why? |
| Dysbiosis | 4 | 2018 | 685 | 1.04 | Why? |
| Alanine Transaminase | 3 | 2018 | 1329 | 0.98 | Why? |
| Chromatography, High Pressure Liquid | 3 | 2019 | 669 | 0.98 | Why? |
| Tuberculosis, Multidrug-Resistant | 2 | 2018 | 433 | 0.95 | Why? |
| Mesenchymal Stem Cell Transplantation | 3 | 2018 | 1322 | 0.92 | Why? |
| T-Lymphocytes, Regulatory | 4 | 2017 | 698 | 0.90 | Why? |
| Gastrointestinal Hemorrhage | 2 | 2019 | 669 | 0.88 | Why? |
| Carbon Tetrachloride | 2 | 2017 | 27 | 0.88 | Why? |
| Gastrointestinal Tract | 3 | 2020 | 1113 | 0.87 | Why? |
| Antitubercular Agents | 2 | 2018 | 775 | 0.87 | Why? |
| Galactosamine | 5 | 2018 | 18 | 0.86 | Why? |
| Hepatic Encephalopathy | 2 | 2018 | 88 | 0.86 | Why? |
| Hepatitis C, Chronic | 3 | 2019 | 973 | 0.86 | Why? |
| Bacteria | 6 | 2018 | 1897 | 0.86 | Why? |
| Chemical and Drug Induced Liver Injury | 2 | 2018 | 451 | 0.85 | Why? |
| Sequence Analysis, DNA | 4 | 2018 | 2830 | 0.81 | Why? |
| Clostridium Infections | 2 | 2017 | 595 | 0.81 | Why? |
| China | 37 | 2021 | 50654 | 0.80 | Why? |
| Genome, Bacterial | 3 | 2017 | 446 | 0.80 | Why? |
| Liver Function Tests | 7 | 2020 | 1325 | 0.79 | Why? |
| Probiotics | 2 | 2018 | 694 | 0.79 | Why? |
| Bacterial Infections | 3 | 2018 | 2229 | 0.79 | Why? |
| Bifidobacterium adolescentis | 1 | 2018 | 2 | 0.79 | Why? |
| Liver Diseases | 4 | 2020 | 2698 | 0.79 | Why? |
| Regenerative Medicine | 2 | 2018 | 161 | 0.78 | Why? |
| Bacteremia | 3 | 2019 | 1372 | 0.77 | Why? |
| Industrial Microbiology | 1 | 2018 | 20 | 0.76 | Why? |
| Hepatitis B Antibodies | 3 | 2017 | 142 | 0.74 | Why? |
| Antioxidants | 2 | 2019 | 1593 | 0.74 | Why? |
| Citrobacter freundii | 1 | 2018 | 14 | 0.74 | Why? |
| Pediococcus pentosaceus | 1 | 2017 | 1 | 0.72 | Why? |
| Lactobacillus salivarius | 1 | 2017 | 2 | 0.72 | Why? |
| Vibrio | 1 | 2017 | 8 | 0.72 | Why? |
| Intestine, Small | 2 | 2018 | 336 | 0.72 | Why? |
| Phlebotomus Fever | 1 | 2018 | 44 | 0.72 | Why? |
| Retinol-Binding Proteins, Plasma | 1 | 2017 | 4 | 0.70 | Why? |
| Bioreactors | 1 | 2018 | 115 | 0.70 | Why? |
| Hepatorenal Syndrome | 1 | 2017 | 26 | 0.70 | Why? |
| DNA Transposable Elements | 1 | 2018 | 91 | 0.70 | Why? |
| Ischemic Preconditioning | 1 | 2018 | 43 | 0.70 | Why? |
| Mitochondria, Liver | 1 | 2017 | 18 | 0.69 | Why? |
| Bile | 1 | 2017 | 56 | 0.69 | Why? |
| Dynamins | 1 | 2017 | 19 | 0.68 | Why? |
| Cyclooxygenase 2 | 1 | 2018 | 129 | 0.68 | Why? |
| Chemoembolization, Therapeutic | 1 | 2018 | 144 | 0.68 | Why? |
| Mitochondrial Dynamics | 1 | 2017 | 30 | 0.67 | Why? |
| Viridans Streptococci | 1 | 2016 | 4 | 0.67 | Why? |
| JC Virus | 1 | 2017 | 39 | 0.67 | Why? |
| Phlebovirus | 1 | 2018 | 106 | 0.67 | Why? |
| Hepatitis B e Antigens | 1 | 2017 | 99 | 0.67 | Why? |
| Tandem Mass Spectrometry | 3 | 2019 | 1031 | 0.67 | Why? |
| Bacterial Translocation | 1 | 2017 | 39 | 0.66 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 187 | 0.66 | Why? |
| Tenofovir | 2 | 2018 | 449 | 0.65 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.65 | Why? |
| Cell Culture Techniques | 2 | 2018 | 704 | 0.64 | Why? |
| Sofosbuvir | 2 | 2018 | 518 | 0.64 | Why? |
| Protective Agents | 1 | 2019 | 250 | 0.64 | Why? |
| Virulence Factors | 3 | 2018 | 338 | 0.63 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 234 | 0.62 | Why? |
| Thyroxine | 1 | 2018 | 250 | 0.62 | Why? |
| Computer Graphics | 1 | 2017 | 124 | 0.62 | Why? |
| Ebola Vaccines | 1 | 2017 | 126 | 0.62 | Why? |
| Influenza, Human | 6 | 2019 | 10779 | 0.62 | Why? |
| CD4 Antigens | 1 | 2017 | 306 | 0.61 | Why? |
| Mouth | 1 | 2021 | 622 | 0.61 | Why? |
| Tumor Virus Infections | 1 | 2017 | 127 | 0.61 | Why? |
| DNA Helicases | 1 | 2017 | 203 | 0.61 | Why? |
| Feces | 6 | 2021 | 4235 | 0.61 | Why? |
| Neuraminidase | 1 | 2018 | 289 | 0.60 | Why? |
| Jaundice | 1 | 2017 | 114 | 0.60 | Why? |
| BK Virus | 1 | 2017 | 135 | 0.60 | Why? |
| Serum | 1 | 2017 | 294 | 0.60 | Why? |
| Cell Death | 1 | 2018 | 536 | 0.60 | Why? |
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2017 | 203 | 0.60 | Why? |
| Polyomavirus Infections | 1 | 2017 | 156 | 0.59 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.59 | Why? |
| Intestines | 2 | 2018 | 817 | 0.59 | Why? |
| Colistin | 1 | 2018 | 217 | 0.58 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.58 | Why? |
| Hepatectomy | 1 | 2018 | 276 | 0.58 | Why? |
| Reperfusion Injury | 1 | 2017 | 178 | 0.58 | Why? |
| Hemoptysis | 1 | 2017 | 172 | 0.57 | Why? |
| Esophageal and Gastric Varices | 1 | 2016 | 117 | 0.56 | Why? |
| Hemorrhagic Fever, Ebola | 2 | 2017 | 1475 | 0.56 | Why? |
| Rats, Sprague-Dawley | 4 | 2019 | 987 | 0.56 | Why? |
| Candidiasis | 1 | 2019 | 334 | 0.55 | Why? |
| Mammals | 1 | 2017 | 315 | 0.55 | Why? |
| Endocytosis | 1 | 2017 | 451 | 0.55 | Why? |
| Epstein-Barr Virus Infections | 1 | 2018 | 366 | 0.55 | Why? |
| Ribavirin | 2 | 2018 | 1182 | 0.54 | Why? |
| Osteoarthritis | 1 | 2017 | 205 | 0.54 | Why? |
| International Classification of Diseases | 1 | 2017 | 265 | 0.54 | Why? |
| Male | 60 | 2021 | 367725 | 0.54 | Why? |
| Mitochondria | 2 | 2018 | 857 | 0.54 | Why? |
| Histones | 1 | 2017 | 371 | 0.54 | Why? |
| Urine | 1 | 2017 | 469 | 0.53 | Why? |
| Lipids | 1 | 2021 | 1079 | 0.53 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.53 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.53 | Why? |
| Goals | 1 | 2017 | 335 | 0.53 | Why? |
| Catheter Ablation | 1 | 2018 | 438 | 0.53 | Why? |
| Drug Resistance, Bacterial | 3 | 2018 | 1414 | 0.52 | Why? |
| Ebolavirus | 2 | 2018 | 834 | 0.52 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.52 | Why? |
| Blood Proteins | 1 | 2017 | 551 | 0.52 | Why? |
| Antigen-Presenting Cells | 1 | 2014 | 206 | 0.51 | Why? |
| Biomarkers | 13 | 2021 | 23361 | 0.51 | Why? |
| Muscular Diseases | 1 | 2019 | 392 | 0.51 | Why? |
| Interferon-alpha | 2 | 2018 | 1442 | 0.51 | Why? |
| Humans | 98 | 2021 | 930598 | 0.50 | Why? |
| Antibodies, Anti-Idiotypic | 1 | 2013 | 93 | 0.50 | Why? |
| Ethanol | 1 | 2018 | 533 | 0.50 | Why? |
| Streptococcal Infections | 1 | 2016 | 255 | 0.49 | Why? |
| Middle Aged | 48 | 2021 | 270681 | 0.49 | Why? |
| Latent Tuberculosis | 1 | 2017 | 324 | 0.49 | Why? |
| RNA, Long Noncoding | 1 | 2017 | 408 | 0.49 | Why? |
| Magnoliopsida | 1 | 2012 | 36 | 0.48 | Why? |
| Bacterial Proteins | 3 | 2018 | 1318 | 0.48 | Why? |
| Melatonin | 1 | 2019 | 578 | 0.48 | Why? |
| RNA, Ribosomal, 16S | 4 | 2018 | 793 | 0.47 | Why? |
| Female | 55 | 2021 | 380317 | 0.47 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.47 | Why? |
| Nanostructures | 2 | 2017 | 700 | 0.47 | Why? |
| Communicable Diseases | 2 | 2017 | 2148 | 0.47 | Why? |
| Cytomegalovirus Infections | 1 | 2018 | 667 | 0.46 | Why? |
| DNA, Viral | 4 | 2017 | 2521 | 0.46 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2019 | 676 | 0.46 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2017 | 436 | 0.46 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.46 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.46 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.45 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.45 | Why? |
| Tuberculosis | 2 | 2018 | 2895 | 0.45 | Why? |
| Lipopolysaccharide Receptors | 1 | 2014 | 357 | 0.44 | Why? |
| Endocarditis, Bacterial | 1 | 2016 | 344 | 0.44 | Why? |
| Disease Notification | 1 | 2017 | 639 | 0.43 | Why? |
| Delayed Diagnosis | 2 | 2018 | 1529 | 0.43 | Why? |
| Genetic Vectors | 1 | 2018 | 1600 | 0.43 | Why? |
| Antigen Presentation | 1 | 2014 | 524 | 0.42 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.42 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.42 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 159 | 0.42 | Why? |
| Adult | 40 | 2021 | 244371 | 0.42 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.42 | Why? |
| Disease Progression | 6 | 2019 | 13580 | 0.41 | Why? |
| Hepatitis B Core Antigens | 1 | 2010 | 76 | 0.41 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2017 | 634 | 0.41 | Why? |
| Models, Statistical | 2 | 2018 | 5312 | 0.41 | Why? |
| Clinical Laboratory Services | 1 | 2017 | 781 | 0.40 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.40 | Why? |
| Metabolic Syndrome | 1 | 2018 | 810 | 0.40 | Why? |
| Hepatitis C | 2 | 2018 | 1514 | 0.40 | Why? |
| Algorithms | 2 | 2017 | 7346 | 0.40 | Why? |
| Animals | 22 | 2019 | 78931 | 0.40 | Why? |
| Cell Proliferation | 5 | 2018 | 1973 | 0.39 | Why? |
| Hepacivirus | 2 | 2018 | 1509 | 0.39 | Why? |
| Coinfection | 3 | 2018 | 6820 | 0.39 | Why? |
| Klebsiella oxytoca | 1 | 2008 | 8 | 0.39 | Why? |
| Oropharynx | 1 | 2017 | 1581 | 0.38 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.37 | Why? |
| Antiviral Agents | 6 | 2019 | 41703 | 0.37 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.37 | Why? |
| Monitoring, Physiologic | 1 | 2019 | 1956 | 0.35 | Why? |
| Antifungal Agents | 1 | 2019 | 1828 | 0.35 | Why? |
| Graft Rejection | 1 | 2018 | 1766 | 0.35 | Why? |
| Endotoxins | 2 | 2018 | 80 | 0.34 | Why? |
| Placenta | 1 | 2018 | 1531 | 0.34 | Why? |
| Oxygen | 2 | 2018 | 3715 | 0.34 | Why? |
| World Health Organization | 2 | 2017 | 4213 | 0.33 | Why? |
| Enzyme Inhibitors | 1 | 2018 | 1881 | 0.33 | Why? |
| Cough | 2 | 2020 | 4891 | 0.33 | Why? |
| Klebsiella pneumoniae | 2 | 2018 | 658 | 0.33 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.33 | Why? |
| Disease Models, Animal | 7 | 2019 | 10998 | 0.33 | Why? |
| Anti-Bacterial Agents | 7 | 2018 | 10083 | 0.32 | Why? |
| Multilocus Sequence Typing | 2 | 2017 | 264 | 0.32 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.32 | Why? |
| Hand, Foot and Mouth Disease | 2 | 2018 | 115 | 0.31 | Why? |
| Rats | 3 | 2019 | 2764 | 0.31 | Why? |
| Prevalence | 9 | 2019 | 25773 | 0.31 | Why? |
| Markov Chains | 2 | 2019 | 502 | 0.31 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.30 | Why? |
| Extracellular Vesicles | 3 | 2017 | 607 | 0.30 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.30 | Why? |
| Prognosis | 10 | 2020 | 32490 | 0.30 | Why? |
| Transcriptome | 2 | 2018 | 3466 | 0.30 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.30 | Why? |
| Risk Factors | 16 | 2020 | 71621 | 0.30 | Why? |
| Carrier State | 1 | 2017 | 2100 | 0.30 | Why? |
| Odds Ratio | 4 | 2018 | 5861 | 0.29 | Why? |
| Aged | 26 | 2021 | 215776 | 0.29 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.29 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.29 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.29 | Why? |
| Blood Glucose | 1 | 2019 | 3642 | 0.29 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.29 | Why? |
| Phytotherapy | 1 | 2012 | 743 | 0.28 | Why? |
| Survival Analysis | 5 | 2018 | 7592 | 0.28 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.28 | Why? |
| Rural Population | 1 | 2017 | 2408 | 0.27 | Why? |
| Discriminant Analysis | 2 | 2017 | 170 | 0.27 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.27 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.27 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.27 | Why? |
| Biosensing Techniques | 1 | 2018 | 2116 | 0.27 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.26 | Why? |
| Colorectal Neoplasms | 1 | 2018 | 1884 | 0.26 | Why? |
| Least-Squares Analysis | 2 | 2017 | 254 | 0.26 | Why? |
| Gene Expression Regulation, Bacterial | 2 | 2017 | 143 | 0.26 | Why? |
| Fungi | 3 | 2018 | 471 | 0.26 | Why? |
| Time Factors | 7 | 2021 | 31397 | 0.25 | Why? |
| ROC Curve | 4 | 2021 | 6024 | 0.25 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.25 | Why? |
| Microbial Sensitivity Tests | 5 | 2018 | 2886 | 0.24 | Why? |
| Disease-Free Survival | 2 | 2018 | 1654 | 0.24 | Why? |
| Antineoplastic Agents | 1 | 2019 | 3550 | 0.24 | Why? |
| Public Health | 3 | 2017 | 16359 | 0.24 | Why? |
| Methyltransferases | 1 | 2008 | 720 | 0.24 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.24 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 2984 | 0.24 | Why? |
| Multivariate Analysis | 3 | 2018 | 5440 | 0.23 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.23 | Why? |
| Immunogenicity, Vaccine | 1 | 2017 | 4624 | 0.23 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.23 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.22 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.22 | Why? |
| Pneumonia | 2 | 2021 | 5652 | 0.22 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.22 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1014 | 0.22 | Why? |
| Hepatitis B Vaccines | 2 | 2017 | 245 | 0.22 | Why? |
| Carbapenems | 2 | 2019 | 343 | 0.22 | Why? |
| Virus Shedding | 1 | 2018 | 5834 | 0.22 | Why? |
| Young Adult | 13 | 2020 | 93724 | 0.22 | Why? |
| Filtration | 2 | 2017 | 820 | 0.22 | Why? |
| Retrospective Studies | 13 | 2020 | 105322 | 0.21 | Why? |
| Machine Learning | 1 | 2017 | 4395 | 0.21 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.21 | Why? |
| T-Lymphocytes | 2 | 2017 | 6670 | 0.21 | Why? |
| Urinary Bladder Neoplasms | 2 | 2017 | 614 | 0.20 | Why? |
| Models, Theoretical | 1 | 2019 | 6659 | 0.20 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.20 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.20 | Why? |
| Cholic Acids | 1 | 2019 | 4 | 0.20 | Why? |
| Sex Factors | 4 | 2018 | 11014 | 0.20 | Why? |
| Genotype | 6 | 2018 | 4697 | 0.20 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.20 | Why? |
| Flucytosine | 1 | 2019 | 12 | 0.20 | Why? |
| Candida tropicalis | 1 | 2019 | 21 | 0.20 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.20 | Why? |
| Rats, Inbred BN | 1 | 2018 | 13 | 0.20 | Why? |
| Drug Delivery Systems | 3 | 2018 | 1365 | 0.19 | Why? |
| Rats, Inbred Lew | 1 | 2018 | 45 | 0.19 | Why? |
| Choline Deficiency | 1 | 2018 | 3 | 0.19 | Why? |
| Peptide Fragments | 1 | 2010 | 2075 | 0.19 | Why? |
| Octamer Transcription Factor-3 | 1 | 2018 | 17 | 0.19 | Why? |
| Bombyx | 1 | 2018 | 35 | 0.19 | Why? |
| Conjugation, Genetic | 1 | 2018 | 12 | 0.19 | Why? |
| Membrane Glycoproteins | 2 | 2018 | 2273 | 0.19 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.19 | Why? |
| Methionine | 1 | 2018 | 53 | 0.18 | Why? |
| Ethanolamines | 1 | 2019 | 71 | 0.18 | Why? |
| Bacterial Physiological Phenomena | 1 | 2017 | 31 | 0.18 | Why? |
| Swine | 2 | 2018 | 3352 | 0.18 | Why? |
| Transcription Factor AP-1 | 1 | 2018 | 75 | 0.18 | Why? |
| Coxsackievirus Infections | 1 | 2018 | 71 | 0.18 | Why? |
| Whole Genome Sequencing | 3 | 2018 | 3239 | 0.18 | Why? |
| Electromagnetic Fields | 1 | 2018 | 34 | 0.18 | Why? |
| Cell-Penetrating Peptides | 1 | 2017 | 24 | 0.18 | Why? |
| Cell Size | 1 | 2018 | 106 | 0.18 | Why? |
| Gene Transfer, Horizontal | 1 | 2018 | 64 | 0.18 | Why? |
| Sequence Analysis, RNA | 2 | 2018 | 2290 | 0.18 | Why? |
| Geologic Sediments | 1 | 2018 | 43 | 0.18 | Why? |
| Ammonia | 1 | 2018 | 61 | 0.18 | Why? |
| Hepatitis B Antigens | 1 | 2017 | 19 | 0.18 | Why? |
| Cross-Sectional Studies | 8 | 2020 | 53120 | 0.18 | Why? |
| Gene Order | 1 | 2018 | 144 | 0.18 | Why? |
| Polysorbates | 1 | 2018 | 125 | 0.18 | Why? |
| Leg | 1 | 2019 | 142 | 0.17 | Why? |
| Swine, Miniature | 1 | 2017 | 33 | 0.17 | Why? |
| Thyroid Function Tests | 1 | 2018 | 200 | 0.17 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.17 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.17 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2018 | 358 | 0.17 | Why? |
| alpha-Fetoproteins | 1 | 2017 | 72 | 0.17 | Why? |
| Longitudinal Studies | 3 | 2018 | 9893 | 0.17 | Why? |
| Guanine | 1 | 2018 | 146 | 0.17 | Why? |
| Acute-Phase Proteins | 1 | 2018 | 177 | 0.17 | Why? |
| Cell Hypoxia | 1 | 2018 | 141 | 0.17 | Why? |
| Cell Transdifferentiation | 1 | 2017 | 47 | 0.17 | Why? |
| Hepatitis, Viral, Human | 1 | 2020 | 196 | 0.17 | Why? |
| Menarche | 1 | 2017 | 21 | 0.17 | Why? |
| Amphotericin B | 1 | 2019 | 256 | 0.17 | Why? |
| Blood Urea Nitrogen | 1 | 2018 | 206 | 0.17 | Why? |
| Hemofiltration | 1 | 2019 | 155 | 0.17 | Why? |
| Hemagglutinins | 1 | 2018 | 143 | 0.17 | Why? |
| Squalene | 1 | 2018 | 196 | 0.17 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.17 | Why? |
| Cecum | 1 | 2017 | 63 | 0.17 | Why? |
| DNA, Bacterial | 2 | 2018 | 835 | 0.16 | Why? |
| Cell Movement | 2 | 2018 | 695 | 0.16 | Why? |
| Mice, Inbred BALB C | 5 | 2018 | 5814 | 0.16 | Why? |
| Ascites | 1 | 2017 | 65 | 0.16 | Why? |
| Cloud Computing | 1 | 2019 | 214 | 0.16 | Why? |
| Genes, Bacterial | 1 | 2018 | 207 | 0.16 | Why? |
| Herpesviridae Infections | 1 | 2018 | 172 | 0.16 | Why? |
| Phylogeny | 6 | 2018 | 13341 | 0.16 | Why? |
| Berberine | 1 | 2017 | 98 | 0.16 | Why? |
| Cell Line, Tumor | 4 | 2018 | 3608 | 0.16 | Why? |
| Ligation | 1 | 2016 | 84 | 0.16 | Why? |
| Sustained Virologic Response | 1 | 2018 | 378 | 0.16 | Why? |
| Publication Bias | 1 | 2018 | 241 | 0.16 | Why? |
| Calcitonin | 1 | 2018 | 201 | 0.16 | Why? |
| Gene Ontology | 1 | 2018 | 391 | 0.16 | Why? |
| Unrelated Donors | 1 | 2017 | 187 | 0.16 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.16 | Why? |
| Lysine | 1 | 2017 | 153 | 0.16 | Why? |
| Abscess | 1 | 2019 | 234 | 0.16 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.16 | Why? |
| Histocompatibility Testing | 1 | 2017 | 219 | 0.16 | Why? |
| Drugs, Chinese Herbal | 1 | 2012 | 2760 | 0.16 | Why? |
| Adolescent | 9 | 2020 | 86841 | 0.15 | Why? |
| Molecular Typing | 1 | 2017 | 280 | 0.15 | Why? |
| Joints | 1 | 2017 | 97 | 0.15 | Why? |
| Bone Marrow Cells | 1 | 2017 | 186 | 0.15 | Why? |
| Bacterial Toxins | 1 | 2017 | 185 | 0.15 | Why? |
| Tissue Engineering | 1 | 2018 | 190 | 0.15 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2018 | 1115 | 0.15 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.15 | Why? |
| Age Factors | 4 | 2018 | 21039 | 0.15 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2018 | 640 | 0.15 | Why? |
| Reproducibility of Results | 5 | 2019 | 11304 | 0.15 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 245 | 0.15 | Why? |
| Siblings | 1 | 2017 | 226 | 0.15 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.15 | Why? |
| Incidence | 4 | 2018 | 25622 | 0.15 | Why? |
| Tumor Microenvironment | 1 | 2017 | 264 | 0.15 | Why? |
| Metabolic Networks and Pathways | 1 | 2017 | 285 | 0.15 | Why? |
| Tacrolimus | 1 | 2018 | 435 | 0.15 | Why? |
| Microfluidics | 1 | 2017 | 171 | 0.15 | Why? |
| Cholangiocarcinoma | 1 | 2018 | 186 | 0.15 | Why? |
| Philippines | 1 | 2018 | 568 | 0.15 | Why? |
| Rivers | 1 | 2018 | 304 | 0.15 | Why? |
| Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.15 | Why? |
| Herpesvirus 4, Human | 1 | 2018 | 387 | 0.15 | Why? |
| Bile Duct Neoplasms | 1 | 2018 | 172 | 0.14 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.14 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.14 | Why? |
| Disease | 1 | 2017 | 126 | 0.14 | Why? |
| Fatty Liver | 1 | 2019 | 299 | 0.14 | Why? |
| Transplantation Conditioning | 1 | 2017 | 323 | 0.14 | Why? |
| Mice | 5 | 2018 | 21357 | 0.14 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.14 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.14 | Why? |
| Injections, Intramuscular | 1 | 2017 | 800 | 0.14 | Why? |
| Iatrogenic Disease | 1 | 2017 | 304 | 0.14 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.14 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.14 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.14 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.14 | Why? |
| Acute Disease | 2 | 2017 | 6029 | 0.14 | Why? |
| Biofilms | 1 | 2017 | 304 | 0.14 | Why? |
| Principal Component Analysis | 1 | 2017 | 689 | 0.14 | Why? |
| Endosomes | 1 | 2017 | 490 | 0.14 | Why? |
| Gene Expression Regulation | 2 | 2017 | 4020 | 0.14 | Why? |
| End Stage Liver Disease | 1 | 2019 | 418 | 0.14 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.14 | Why? |
| Transplantation, Homologous | 1 | 2017 | 757 | 0.13 | Why? |
| Hepatocytes | 1 | 2017 | 549 | 0.13 | Why? |
| Immunity, Cellular | 2 | 2017 | 3614 | 0.13 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.13 | Why? |
| Glycoproteins | 1 | 2018 | 615 | 0.13 | Why? |
| Virulence | 2 | 2018 | 2172 | 0.13 | Why? |
| Protein Processing, Post-Translational | 1 | 2017 | 634 | 0.13 | Why? |
| Thailand | 1 | 2018 | 1155 | 0.13 | Why? |
| Polyethylene Glycols | 1 | 2018 | 574 | 0.13 | Why? |
| Fever | 3 | 2020 | 7795 | 0.13 | Why? |
| Fibrosis | 1 | 2017 | 800 | 0.13 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.13 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.13 | Why? |
| Klebsiella Infections | 1 | 2018 | 466 | 0.13 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.13 | Why? |
| Microbial Viability | 1 | 2017 | 406 | 0.12 | Why? |
| Causality | 1 | 2017 | 857 | 0.12 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2010 | 5837 | 0.12 | Why? |
| Lab-On-A-Chip Devices | 1 | 2017 | 411 | 0.12 | Why? |
| bcl-2-Associated X Protein | 1 | 2012 | 45 | 0.12 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.12 | Why? |
| Syphilis | 1 | 2017 | 318 | 0.12 | Why? |
| Hospitals, University | 3 | 2018 | 4173 | 0.12 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.12 | Why? |
| Pseudomonas Infections | 1 | 2017 | 425 | 0.12 | Why? |
| Spleen | 1 | 2017 | 877 | 0.12 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.12 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.12 | Why? |
| Glucose | 1 | 2017 | 573 | 0.12 | Why? |
| Sensitivity and Specificity | 3 | 2018 | 22971 | 0.12 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.12 | Why? |
| Opportunistic Infections | 1 | 2019 | 602 | 0.12 | Why? |
| Polymers | 1 | 2017 | 507 | 0.12 | Why? |
| fas Receptor | 1 | 2012 | 85 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.12 | Why? |
| Muscle, Skeletal | 1 | 2019 | 915 | 0.11 | Why? |
| Immunocompromised Host | 2 | 2019 | 5150 | 0.11 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.11 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.11 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.11 | Why? |
| Mutagenesis, Insertional | 1 | 2011 | 92 | 0.11 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 127 | 0.11 | Why? |
| Th17 Cells | 1 | 2017 | 657 | 0.11 | Why? |
| Decision Support Systems, Clinical | 1 | 2017 | 551 | 0.11 | Why? |
| Steroids | 1 | 2017 | 904 | 0.11 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2017 | 760 | 0.11 | Why? |
| HLA-DR Antigens | 1 | 2014 | 563 | 0.11 | Why? |
| Area Under Curve | 1 | 2019 | 2564 | 0.11 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.11 | Why? |
| Occupations | 1 | 2017 | 733 | 0.11 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.11 | Why? |
| Amino Acid Sequence | 4 | 2018 | 6049 | 0.11 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.11 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.11 | Why? |
| Risk Assessment | 4 | 2019 | 25439 | 0.11 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.11 | Why? |
| Antibodies, Viral | 3 | 2018 | 51949 | 0.11 | Why? |
| Th1 Cells | 1 | 2017 | 1228 | 0.11 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.10 | Why? |
| Shock | 1 | 2018 | 1868 | 0.10 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.10 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.10 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.10 | Why? |
| Community Health Services | 1 | 2019 | 1000 | 0.10 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.10 | Why? |
| Cell Count | 1 | 2010 | 228 | 0.10 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.10 | Why? |
| Base Sequence | 3 | 2018 | 3581 | 0.10 | Why? |
| HLA-A2 Antigen | 1 | 2010 | 134 | 0.10 | Why? |
| Cell Adhesion | 1 | 2010 | 230 | 0.10 | Why? |
| Small Molecule Libraries | 1 | 2018 | 1060 | 0.10 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.10 | Why? |
| Seroepidemiologic Studies | 2 | 2017 | 10017 | 0.10 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.09 | Why? |
| Hong Kong | 1 | 2018 | 3361 | 0.09 | Why? |
| Vitamins | 1 | 2018 | 1208 | 0.09 | Why? |
| Genomics | 2 | 2017 | 3118 | 0.09 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.09 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
| Africa | 1 | 2017 | 2986 | 0.09 | Why? |
| Singapore | 1 | 2018 | 3641 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2018 | 7868 | 0.09 | Why? |
| Cell Communication | 1 | 2010 | 396 | 0.09 | Why? |
| HEK293 Cells | 2 | 2018 | 8394 | 0.09 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2018 | 13720 | 0.09 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.09 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.08 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Sequence Deletion | 1 | 2011 | 674 | 0.08 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.08 | Why? |
| Seroconversion | 1 | 2017 | 2515 | 0.08 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Models, Biological | 2 | 2021 | 4907 | 0.08 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.08 | Why? |
| Infant, Newborn | 2 | 2017 | 23105 | 0.08 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.08 | Why? |
| Child | 4 | 2020 | 70012 | 0.07 | Why? |
| Interferons | 1 | 2018 | 2885 | 0.07 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.07 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.07 | Why? |
| beta-Lactam Resistance | 1 | 2006 | 150 | 0.07 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2016 | 1545 | 0.07 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.07 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Risk | 1 | 2017 | 5288 | 0.07 | Why? |
| Skin | 1 | 2017 | 2096 | 0.07 | Why? |
| Australia | 1 | 2018 | 6306 | 0.07 | Why? |
| Japan | 1 | 2018 | 6653 | 0.07 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.07 | Why? |
| Arrhythmias, Cardiac | 1 | 2018 | 2510 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Neutralization Tests | 1 | 2018 | 6698 | 0.07 | Why? |
| Infant | 2 | 2017 | 30274 | 0.07 | Why? |
| Amino Acid Substitution | 1 | 2011 | 1706 | 0.07 | Why? |
| Laboratories | 1 | 2017 | 2858 | 0.07 | Why? |
| Molecular Sequence Data | 2 | 2006 | 3198 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.06 | Why? |
| Hematologic Neoplasms | 1 | 2017 | 2105 | 0.06 | Why? |
| Developing Countries | 1 | 2019 | 4283 | 0.06 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
| Hypoxia | 1 | 2018 | 3626 | 0.06 | Why? |
| Child, Preschool | 2 | 2017 | 36283 | 0.06 | Why? |
| Serologic Tests | 1 | 2017 | 4359 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2018 | 88759 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.06 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.06 | Why? |
| Azithromycin | 1 | 2017 | 3943 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.06 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2012 | 2483 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.05 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.05 | Why? |
| Immunomodulation | 1 | 2010 | 1472 | 0.05 | Why? |
| Antibodies, Neutralizing | 2 | 2018 | 25288 | 0.05 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.05 | Why? |
| Lung | 3 | 2018 | 31049 | 0.05 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.05 | Why? |
| Domestication | 1 | 2018 | 3 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Moths | 1 | 2018 | 24 | 0.05 | Why? |
| Health Policy | 1 | 2019 | 6242 | 0.05 | Why? |
| Pyocyanine | 1 | 2017 | 3 | 0.05 | Why? |
| Morus | 1 | 2018 | 41 | 0.05 | Why? |
| Glucuronic Acid | 1 | 2017 | 11 | 0.05 | Why? |
| Hexuronic Acids | 1 | 2017 | 11 | 0.05 | Why? |
| Chitinases | 1 | 2017 | 8 | 0.04 | Why? |
| Cytoskeleton | 1 | 2018 | 99 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| Polymorphism, Genetic | 1 | 2005 | 1074 | 0.04 | Why? |
| Metalloendopeptidases | 1 | 2017 | 35 | 0.04 | Why? |
| Alginates | 1 | 2017 | 46 | 0.04 | Why? |
| Registries | 1 | 2018 | 12327 | 0.04 | Why? |
| Metalloproteases | 1 | 2017 | 34 | 0.04 | Why? |
| Sequence Analysis, Protein | 1 | 2018 | 309 | 0.04 | Why? |
| Rheology | 1 | 2017 | 70 | 0.04 | Why? |
| Chromatography, Gel | 1 | 2017 | 71 | 0.04 | Why? |
| Mice, Nude | 1 | 2018 | 340 | 0.04 | Why? |
| DNA Copy Number Variations | 1 | 2017 | 84 | 0.04 | Why? |
| Genetic Variation | 1 | 2011 | 3919 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| Integrins | 1 | 2018 | 158 | 0.04 | Why? |
| Antigen-Antibody Reactions | 1 | 2018 | 616 | 0.04 | Why? |
| Molecular Weight | 1 | 2017 | 249 | 0.04 | Why? |
| Colony Count, Microbial | 1 | 2017 | 177 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Hospitalization | 2 | 2018 | 54280 | 0.04 | Why? |
| Serogroup | 1 | 2018 | 510 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
| International Normalized Ratio | 1 | 2017 | 300 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Cyclophosphamide | 1 | 2017 | 387 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Cell Adhesion Molecules | 1 | 2018 | 472 | 0.04 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
| Kinetics | 2 | 2017 | 3238 | 0.04 | Why? |
| Biocompatible Materials | 1 | 2017 | 214 | 0.03 | Why? |
| Evolution, Molecular | 2 | 2005 | 3691 | 0.03 | Why? |
| Hemolysis | 1 | 2017 | 283 | 0.03 | Why? |
| Cell Line | 1 | 2010 | 12040 | 0.03 | Why? |
| Bilirubin | 1 | 2017 | 503 | 0.03 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.03 | Why? |
| Interleukin-6 | 1 | 2012 | 7522 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Neutropenia | 1 | 2017 | 388 | 0.03 | Why? |
| Oligopeptides | 1 | 2017 | 576 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Open Reading Frames | 1 | 2018 | 1898 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Genome, Viral | 2 | 2011 | 13157 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| SARS Virus | 2 | 2005 | 13021 | 0.03 | Why? |
| United States | 1 | 2018 | 46150 | 0.03 | Why? |
| RNA, Viral | 1 | 2018 | 32276 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.02 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Microscopy, Electron, Transmission | 1 | 2011 | 605 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.02 | Why? |
| Antigen-Antibody Complex | 1 | 2008 | 408 | 0.02 | Why? |
| Cell Membrane | 1 | 2011 | 743 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Databases, Nucleic Acid | 1 | 2005 | 272 | 0.02 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.01 | Why? |
| Selection, Genetic | 1 | 2005 | 691 | 0.01 | Why? |
| Point Mutation | 1 | 2004 | 481 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.01 | Why? |